About Us

By harnessing insights from human genetics, neuroscience, and immunology, we’re advancing innovative therapies that have the potential to counteract the devastating progression of neurodegenerative diseases.

Through a combination of relentless curiosity, exquisite science and technology, and a determination to make a difference, we’re building an ambitious pipeline of potential first- and best-in-class therapeutic candidates designed to remove toxic proteins, replace deficient proteins, and restore immune and nerve cell function.

With deep expertise in drug development, protein engineering, and antibody discovery, combined with our proprietary Alector Brain Carrier (ABC) technology for blood-brain barrier transport, we’re advancing our pipeline to deliver potentially transformative therapies aimed at addressing critical unmet needs.

We’re compelled to seek treatments in the hope of improving the lives of patients, caregivers, and families whose lives are devastated by neurodegenerative diseases such as frontotemporal dementia, Alzheimer’s, Parkinson’s, and others.

At Alector, we aren’t just developing therapeutics – we aim to make brain disorders history. Because we believe that every mind deserves a lifetime.